Global Biomacromolecule CDMO Supply, Demand and Key Producers, 2023-2029
The global Biomacromolecule CDMO market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
The macromolecule CDMO industry refers to drugs that rely on cell biosynthesis, usually with a molecular weight greater than 1,000. Macromolecule CDMO mainly focuses on biopharmaceuticals, and the intermediates are relatively unified, mainly including some raw materials, protein and antibody preparation, stable cell lines and process development, and the production and research and development of biological preparations.
This report studies the global Biomacromolecule CDMO demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biomacromolecule CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biomacromolecule CDMO that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biomacromolecule CDMO total market, 2018-2029, (USD Million)
Global Biomacromolecule CDMO total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Biomacromolecule CDMO total market, key domestic companies and share, (USD Million)
Global Biomacromolecule CDMO revenue by player and market share 2018-2023, (USD Million)
Global Biomacromolecule CDMO total market by Type, CAGR, 2018-2029, (USD Million)
Global Biomacromolecule CDMO total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Biomacromolecule CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Wuxi Biologics (Cayman) Inc., Catalent, Thermo Fisher Scientific, Samsung Biologics, Rentschler Biopharma, Baxter Biopharma Solutions, Merck BioReliance and Cytovance Biologics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biomacromolecule CDMO market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Biomacromolecule CDMO Market, By Region:
1. How big is the global Biomacromolecule CDMO market?
2. What is the demand of the global Biomacromolecule CDMO market?
3. What is the year over year growth of the global Biomacromolecule CDMO market?
4. What is the total value of the global Biomacromolecule CDMO market?
5. Who are the major players in the global Biomacromolecule CDMO market?
The macromolecule CDMO industry refers to drugs that rely on cell biosynthesis, usually with a molecular weight greater than 1,000. Macromolecule CDMO mainly focuses on biopharmaceuticals, and the intermediates are relatively unified, mainly including some raw materials, protein and antibody preparation, stable cell lines and process development, and the production and research and development of biological preparations.
This report studies the global Biomacromolecule CDMO demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biomacromolecule CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biomacromolecule CDMO that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biomacromolecule CDMO total market, 2018-2029, (USD Million)
Global Biomacromolecule CDMO total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Biomacromolecule CDMO total market, key domestic companies and share, (USD Million)
Global Biomacromolecule CDMO revenue by player and market share 2018-2023, (USD Million)
Global Biomacromolecule CDMO total market by Type, CAGR, 2018-2029, (USD Million)
Global Biomacromolecule CDMO total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Biomacromolecule CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Wuxi Biologics (Cayman) Inc., Catalent, Thermo Fisher Scientific, Samsung Biologics, Rentschler Biopharma, Baxter Biopharma Solutions, Merck BioReliance and Cytovance Biologics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biomacromolecule CDMO market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Biomacromolecule CDMO Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Biologics CDMO
- Viral Vaccine Production CDMO
- Analyze and Test CDMOs
- Others
- Drug Development
- Vaccine Production
- Technology Transfer
- Others
- Lonza
- Wuxi Biologics (Cayman) Inc.
- Catalent
- Thermo Fisher Scientific
- Samsung Biologics
- Rentschler Biopharma
- Baxter Biopharma Solutions
- Merck BioReliance
- Cytovance Biologics
- AGC Biologics
- Abzena
- Emergent BioSolutions
- ProBioGen
- Goodwin Biotechnology
- KBI Biopharma
- Asymchem Laboratories (Tianjin) Co., Ltd.
- Shanghai Chempartner Lifescience Co., Ltd.
- Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd.
- Genscript Biotech
- Beijing Joinn Biologics Co., Ltd.
1. How big is the global Biomacromolecule CDMO market?
2. What is the demand of the global Biomacromolecule CDMO market?
3. What is the year over year growth of the global Biomacromolecule CDMO market?
4. What is the total value of the global Biomacromolecule CDMO market?
5. Who are the major players in the global Biomacromolecule CDMO market?
1 SUPPLY SUMMARY
1.1 Biomacromolecule CDMO Introduction
1.2 World Biomacromolecule CDMO Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Biomacromolecule CDMO Total Market by Region (by Headquarter Location)
1.3.1 World Biomacromolecule CDMO Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Biomacromolecule CDMO Market Size (2018-2029)
1.3.3 China Biomacromolecule CDMO Market Size (2018-2029)
1.3.4 Europe Biomacromolecule CDMO Market Size (2018-2029)
1.3.5 Japan Biomacromolecule CDMO Market Size (2018-2029)
1.3.6 South Korea Biomacromolecule CDMO Market Size (2018-2029)
1.3.7 ASEAN Biomacromolecule CDMO Market Size (2018-2029)
1.3.8 India Biomacromolecule CDMO Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biomacromolecule CDMO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biomacromolecule CDMO Major Market Trends
2 DEMAND SUMMARY
2.1 World Biomacromolecule CDMO Consumption Value (2018-2029)
2.2 World Biomacromolecule CDMO Consumption Value by Region
2.2.1 World Biomacromolecule CDMO Consumption Value by Region (2018-2023)
2.2.2 World Biomacromolecule CDMO Consumption Value Forecast by Region (2024-2029)
2.3 United States Biomacromolecule CDMO Consumption Value (2018-2029)
2.4 China Biomacromolecule CDMO Consumption Value (2018-2029)
2.5 Europe Biomacromolecule CDMO Consumption Value (2018-2029)
2.6 Japan Biomacromolecule CDMO Consumption Value (2018-2029)
2.7 South Korea Biomacromolecule CDMO Consumption Value (2018-2029)
2.8 ASEAN Biomacromolecule CDMO Consumption Value (2018-2029)
2.9 India Biomacromolecule CDMO Consumption Value (2018-2029)
3 WORLD BIOMACROMOLECULE CDMO COMPANIES COMPETITIVE ANALYSIS
3.1 World Biomacromolecule CDMO Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Biomacromolecule CDMO Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Biomacromolecule CDMO in 2022
3.2.3 Global Concentration Ratios (CR8) for Biomacromolecule CDMO in 2022
3.3 Biomacromolecule CDMO Company Evaluation Quadrant
3.4 Biomacromolecule CDMO Market: Overall Company Footprint Analysis
3.4.1 Biomacromolecule CDMO Market: Region Footprint
3.4.2 Biomacromolecule CDMO Market: Company Product Type Footprint
3.4.3 Biomacromolecule CDMO Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Biomacromolecule CDMO Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Biomacromolecule CDMO Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Biomacromolecule CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Biomacromolecule CDMO Consumption Value Comparison
4.2.1 United States VS China: Biomacromolecule CDMO Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Biomacromolecule CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Biomacromolecule CDMO Companies and Market Share, 2018-2023
4.3.1 United States Based Biomacromolecule CDMO Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Biomacromolecule CDMO Revenue, (2018-2023)
4.4 China Based Companies Biomacromolecule CDMO Revenue and Market Share, 2018-2023
4.4.1 China Based Biomacromolecule CDMO Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Biomacromolecule CDMO Revenue, (2018-2023)
4.5 Rest of World Based Biomacromolecule CDMO Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Biomacromolecule CDMO Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Biomacromolecule CDMO Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Biomacromolecule CDMO Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Biologics CDMO
5.2.2 Viral Vaccine Production CDMO
5.2.3 Analyze and Test CDMOs
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Biomacromolecule CDMO Market Size by Type (2018-2023)
5.3.2 World Biomacromolecule CDMO Market Size by Type (2024-2029)
5.3.3 World Biomacromolecule CDMO Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Biomacromolecule CDMO Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Drug Development
6.2.2 Vaccine Production
6.2.3 Technology Transfer
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Biomacromolecule CDMO Market Size by Application (2018-2023)
6.3.2 World Biomacromolecule CDMO Market Size by Application (2024-2029)
6.3.3 World Biomacromolecule CDMO Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Lonza
7.1.1 Lonza Details
7.1.2 Lonza Major Business
7.1.3 Lonza Biomacromolecule CDMO Product and Services
7.1.4 Lonza Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Lonza Recent Developments/Updates
7.1.6 Lonza Competitive Strengths & Weaknesses
7.2 Wuxi Biologics (Cayman) Inc.
7.2.1 Wuxi Biologics (Cayman) Inc. Details
7.2.2 Wuxi Biologics (Cayman) Inc. Major Business
7.2.3 Wuxi Biologics (Cayman) Inc. Biomacromolecule CDMO Product and Services
7.2.4 Wuxi Biologics (Cayman) Inc. Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Wuxi Biologics (Cayman) Inc. Recent Developments/Updates
7.2.6 Wuxi Biologics (Cayman) Inc. Competitive Strengths & Weaknesses
7.3 Catalent
7.3.1 Catalent Details
7.3.2 Catalent Major Business
7.3.3 Catalent Biomacromolecule CDMO Product and Services
7.3.4 Catalent Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Catalent Recent Developments/Updates
7.3.6 Catalent Competitive Strengths & Weaknesses
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Details
7.4.2 Thermo Fisher Scientific Major Business
7.4.3 Thermo Fisher Scientific Biomacromolecule CDMO Product and Services
7.4.4 Thermo Fisher Scientific Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Thermo Fisher Scientific Recent Developments/Updates
7.4.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.5 Samsung Biologics
7.5.1 Samsung Biologics Details
7.5.2 Samsung Biologics Major Business
7.5.3 Samsung Biologics Biomacromolecule CDMO Product and Services
7.5.4 Samsung Biologics Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Samsung Biologics Recent Developments/Updates
7.5.6 Samsung Biologics Competitive Strengths & Weaknesses
7.6 Rentschler Biopharma
7.6.1 Rentschler Biopharma Details
7.6.2 Rentschler Biopharma Major Business
7.6.3 Rentschler Biopharma Biomacromolecule CDMO Product and Services
7.6.4 Rentschler Biopharma Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Rentschler Biopharma Recent Developments/Updates
7.6.6 Rentschler Biopharma Competitive Strengths & Weaknesses
7.7 Baxter Biopharma Solutions
7.7.1 Baxter Biopharma Solutions Details
7.7.2 Baxter Biopharma Solutions Major Business
7.7.3 Baxter Biopharma Solutions Biomacromolecule CDMO Product and Services
7.7.4 Baxter Biopharma Solutions Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Baxter Biopharma Solutions Recent Developments/Updates
7.7.6 Baxter Biopharma Solutions Competitive Strengths & Weaknesses
7.8 Merck BioReliance
7.8.1 Merck BioReliance Details
7.8.2 Merck BioReliance Major Business
7.8.3 Merck BioReliance Biomacromolecule CDMO Product and Services
7.8.4 Merck BioReliance Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Merck BioReliance Recent Developments/Updates
7.8.6 Merck BioReliance Competitive Strengths & Weaknesses
7.9 Cytovance Biologics
7.9.1 Cytovance Biologics Details
7.9.2 Cytovance Biologics Major Business
7.9.3 Cytovance Biologics Biomacromolecule CDMO Product and Services
7.9.4 Cytovance Biologics Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Cytovance Biologics Recent Developments/Updates
7.9.6 Cytovance Biologics Competitive Strengths & Weaknesses
7.10 AGC Biologics
7.10.1 AGC Biologics Details
7.10.2 AGC Biologics Major Business
7.10.3 AGC Biologics Biomacromolecule CDMO Product and Services
7.10.4 AGC Biologics Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 AGC Biologics Recent Developments/Updates
7.10.6 AGC Biologics Competitive Strengths & Weaknesses
7.11 Abzena
7.11.1 Abzena Details
7.11.2 Abzena Major Business
7.11.3 Abzena Biomacromolecule CDMO Product and Services
7.11.4 Abzena Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Abzena Recent Developments/Updates
7.11.6 Abzena Competitive Strengths & Weaknesses
7.12 Emergent BioSolutions
7.12.1 Emergent BioSolutions Details
7.12.2 Emergent BioSolutions Major Business
7.12.3 Emergent BioSolutions Biomacromolecule CDMO Product and Services
7.12.4 Emergent BioSolutions Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Emergent BioSolutions Recent Developments/Updates
7.12.6 Emergent BioSolutions Competitive Strengths & Weaknesses
7.13 ProBioGen
7.13.1 ProBioGen Details
7.13.2 ProBioGen Major Business
7.13.3 ProBioGen Biomacromolecule CDMO Product and Services
7.13.4 ProBioGen Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 ProBioGen Recent Developments/Updates
7.13.6 ProBioGen Competitive Strengths & Weaknesses
7.14 Goodwin Biotechnology
7.14.1 Goodwin Biotechnology Details
7.14.2 Goodwin Biotechnology Major Business
7.14.3 Goodwin Biotechnology Biomacromolecule CDMO Product and Services
7.14.4 Goodwin Biotechnology Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Goodwin Biotechnology Recent Developments/Updates
7.14.6 Goodwin Biotechnology Competitive Strengths & Weaknesses
7.15 KBI Biopharma
7.15.1 KBI Biopharma Details
7.15.2 KBI Biopharma Major Business
7.15.3 KBI Biopharma Biomacromolecule CDMO Product and Services
7.15.4 KBI Biopharma Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 KBI Biopharma Recent Developments/Updates
7.15.6 KBI Biopharma Competitive Strengths & Weaknesses
7.16 Asymchem Laboratories (Tianjin) Co., Ltd.
7.16.1 Asymchem Laboratories (Tianjin) Co., Ltd. Details
7.16.2 Asymchem Laboratories (Tianjin) Co., Ltd. Major Business
7.16.3 Asymchem Laboratories (Tianjin) Co., Ltd. Biomacromolecule CDMO Product and Services
7.16.4 Asymchem Laboratories (Tianjin) Co., Ltd. Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Asymchem Laboratories (Tianjin) Co., Ltd. Recent Developments/Updates
7.16.6 Asymchem Laboratories (Tianjin) Co., Ltd. Competitive Strengths & Weaknesses
7.17 Shanghai Chempartner Lifescience Co., Ltd.
7.17.1 Shanghai Chempartner Lifescience Co., Ltd. Details
7.17.2 Shanghai Chempartner Lifescience Co., Ltd. Major Business
7.17.3 Shanghai Chempartner Lifescience Co., Ltd. Biomacromolecule CDMO Product and Services
7.17.4 Shanghai Chempartner Lifescience Co., Ltd. Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Shanghai Chempartner Lifescience Co., Ltd. Recent Developments/Updates
7.17.6 Shanghai Chempartner Lifescience Co., Ltd. Competitive Strengths & Weaknesses
7.18 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd.
7.18.1 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Details
7.18.2 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Major Business
7.18.3 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Biomacromolecule CDMO Product and Services
7.18.4 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Recent Developments/Updates
7.18.6 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
7.19 Genscript Biotech
7.19.1 Genscript Biotech Details
7.19.2 Genscript Biotech Major Business
7.19.3 Genscript Biotech Biomacromolecule CDMO Product and Services
7.19.4 Genscript Biotech Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Genscript Biotech Recent Developments/Updates
7.19.6 Genscript Biotech Competitive Strengths & Weaknesses
7.20 Beijing Joinn Biologics Co., Ltd.
7.20.1 Beijing Joinn Biologics Co., Ltd. Details
7.20.2 Beijing Joinn Biologics Co., Ltd. Major Business
7.20.3 Beijing Joinn Biologics Co., Ltd. Biomacromolecule CDMO Product and Services
7.20.4 Beijing Joinn Biologics Co., Ltd. Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Beijing Joinn Biologics Co., Ltd. Recent Developments/Updates
7.20.6 Beijing Joinn Biologics Co., Ltd. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Biomacromolecule CDMO Industry Chain
8.2 Biomacromolecule CDMO Upstream Analysis
8.3 Biomacromolecule CDMO Midstream Analysis
8.4 Biomacromolecule CDMO Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Biomacromolecule CDMO Introduction
1.2 World Biomacromolecule CDMO Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Biomacromolecule CDMO Total Market by Region (by Headquarter Location)
1.3.1 World Biomacromolecule CDMO Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Biomacromolecule CDMO Market Size (2018-2029)
1.3.3 China Biomacromolecule CDMO Market Size (2018-2029)
1.3.4 Europe Biomacromolecule CDMO Market Size (2018-2029)
1.3.5 Japan Biomacromolecule CDMO Market Size (2018-2029)
1.3.6 South Korea Biomacromolecule CDMO Market Size (2018-2029)
1.3.7 ASEAN Biomacromolecule CDMO Market Size (2018-2029)
1.3.8 India Biomacromolecule CDMO Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biomacromolecule CDMO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biomacromolecule CDMO Major Market Trends
2 DEMAND SUMMARY
2.1 World Biomacromolecule CDMO Consumption Value (2018-2029)
2.2 World Biomacromolecule CDMO Consumption Value by Region
2.2.1 World Biomacromolecule CDMO Consumption Value by Region (2018-2023)
2.2.2 World Biomacromolecule CDMO Consumption Value Forecast by Region (2024-2029)
2.3 United States Biomacromolecule CDMO Consumption Value (2018-2029)
2.4 China Biomacromolecule CDMO Consumption Value (2018-2029)
2.5 Europe Biomacromolecule CDMO Consumption Value (2018-2029)
2.6 Japan Biomacromolecule CDMO Consumption Value (2018-2029)
2.7 South Korea Biomacromolecule CDMO Consumption Value (2018-2029)
2.8 ASEAN Biomacromolecule CDMO Consumption Value (2018-2029)
2.9 India Biomacromolecule CDMO Consumption Value (2018-2029)
3 WORLD BIOMACROMOLECULE CDMO COMPANIES COMPETITIVE ANALYSIS
3.1 World Biomacromolecule CDMO Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Biomacromolecule CDMO Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Biomacromolecule CDMO in 2022
3.2.3 Global Concentration Ratios (CR8) for Biomacromolecule CDMO in 2022
3.3 Biomacromolecule CDMO Company Evaluation Quadrant
3.4 Biomacromolecule CDMO Market: Overall Company Footprint Analysis
3.4.1 Biomacromolecule CDMO Market: Region Footprint
3.4.2 Biomacromolecule CDMO Market: Company Product Type Footprint
3.4.3 Biomacromolecule CDMO Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Biomacromolecule CDMO Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Biomacromolecule CDMO Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Biomacromolecule CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Biomacromolecule CDMO Consumption Value Comparison
4.2.1 United States VS China: Biomacromolecule CDMO Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Biomacromolecule CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Biomacromolecule CDMO Companies and Market Share, 2018-2023
4.3.1 United States Based Biomacromolecule CDMO Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Biomacromolecule CDMO Revenue, (2018-2023)
4.4 China Based Companies Biomacromolecule CDMO Revenue and Market Share, 2018-2023
4.4.1 China Based Biomacromolecule CDMO Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Biomacromolecule CDMO Revenue, (2018-2023)
4.5 Rest of World Based Biomacromolecule CDMO Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Biomacromolecule CDMO Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Biomacromolecule CDMO Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Biomacromolecule CDMO Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Biologics CDMO
5.2.2 Viral Vaccine Production CDMO
5.2.3 Analyze and Test CDMOs
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Biomacromolecule CDMO Market Size by Type (2018-2023)
5.3.2 World Biomacromolecule CDMO Market Size by Type (2024-2029)
5.3.3 World Biomacromolecule CDMO Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Biomacromolecule CDMO Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Drug Development
6.2.2 Vaccine Production
6.2.3 Technology Transfer
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Biomacromolecule CDMO Market Size by Application (2018-2023)
6.3.2 World Biomacromolecule CDMO Market Size by Application (2024-2029)
6.3.3 World Biomacromolecule CDMO Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Lonza
7.1.1 Lonza Details
7.1.2 Lonza Major Business
7.1.3 Lonza Biomacromolecule CDMO Product and Services
7.1.4 Lonza Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Lonza Recent Developments/Updates
7.1.6 Lonza Competitive Strengths & Weaknesses
7.2 Wuxi Biologics (Cayman) Inc.
7.2.1 Wuxi Biologics (Cayman) Inc. Details
7.2.2 Wuxi Biologics (Cayman) Inc. Major Business
7.2.3 Wuxi Biologics (Cayman) Inc. Biomacromolecule CDMO Product and Services
7.2.4 Wuxi Biologics (Cayman) Inc. Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Wuxi Biologics (Cayman) Inc. Recent Developments/Updates
7.2.6 Wuxi Biologics (Cayman) Inc. Competitive Strengths & Weaknesses
7.3 Catalent
7.3.1 Catalent Details
7.3.2 Catalent Major Business
7.3.3 Catalent Biomacromolecule CDMO Product and Services
7.3.4 Catalent Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Catalent Recent Developments/Updates
7.3.6 Catalent Competitive Strengths & Weaknesses
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Details
7.4.2 Thermo Fisher Scientific Major Business
7.4.3 Thermo Fisher Scientific Biomacromolecule CDMO Product and Services
7.4.4 Thermo Fisher Scientific Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Thermo Fisher Scientific Recent Developments/Updates
7.4.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.5 Samsung Biologics
7.5.1 Samsung Biologics Details
7.5.2 Samsung Biologics Major Business
7.5.3 Samsung Biologics Biomacromolecule CDMO Product and Services
7.5.4 Samsung Biologics Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Samsung Biologics Recent Developments/Updates
7.5.6 Samsung Biologics Competitive Strengths & Weaknesses
7.6 Rentschler Biopharma
7.6.1 Rentschler Biopharma Details
7.6.2 Rentschler Biopharma Major Business
7.6.3 Rentschler Biopharma Biomacromolecule CDMO Product and Services
7.6.4 Rentschler Biopharma Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Rentschler Biopharma Recent Developments/Updates
7.6.6 Rentschler Biopharma Competitive Strengths & Weaknesses
7.7 Baxter Biopharma Solutions
7.7.1 Baxter Biopharma Solutions Details
7.7.2 Baxter Biopharma Solutions Major Business
7.7.3 Baxter Biopharma Solutions Biomacromolecule CDMO Product and Services
7.7.4 Baxter Biopharma Solutions Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Baxter Biopharma Solutions Recent Developments/Updates
7.7.6 Baxter Biopharma Solutions Competitive Strengths & Weaknesses
7.8 Merck BioReliance
7.8.1 Merck BioReliance Details
7.8.2 Merck BioReliance Major Business
7.8.3 Merck BioReliance Biomacromolecule CDMO Product and Services
7.8.4 Merck BioReliance Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Merck BioReliance Recent Developments/Updates
7.8.6 Merck BioReliance Competitive Strengths & Weaknesses
7.9 Cytovance Biologics
7.9.1 Cytovance Biologics Details
7.9.2 Cytovance Biologics Major Business
7.9.3 Cytovance Biologics Biomacromolecule CDMO Product and Services
7.9.4 Cytovance Biologics Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Cytovance Biologics Recent Developments/Updates
7.9.6 Cytovance Biologics Competitive Strengths & Weaknesses
7.10 AGC Biologics
7.10.1 AGC Biologics Details
7.10.2 AGC Biologics Major Business
7.10.3 AGC Biologics Biomacromolecule CDMO Product and Services
7.10.4 AGC Biologics Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 AGC Biologics Recent Developments/Updates
7.10.6 AGC Biologics Competitive Strengths & Weaknesses
7.11 Abzena
7.11.1 Abzena Details
7.11.2 Abzena Major Business
7.11.3 Abzena Biomacromolecule CDMO Product and Services
7.11.4 Abzena Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Abzena Recent Developments/Updates
7.11.6 Abzena Competitive Strengths & Weaknesses
7.12 Emergent BioSolutions
7.12.1 Emergent BioSolutions Details
7.12.2 Emergent BioSolutions Major Business
7.12.3 Emergent BioSolutions Biomacromolecule CDMO Product and Services
7.12.4 Emergent BioSolutions Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Emergent BioSolutions Recent Developments/Updates
7.12.6 Emergent BioSolutions Competitive Strengths & Weaknesses
7.13 ProBioGen
7.13.1 ProBioGen Details
7.13.2 ProBioGen Major Business
7.13.3 ProBioGen Biomacromolecule CDMO Product and Services
7.13.4 ProBioGen Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 ProBioGen Recent Developments/Updates
7.13.6 ProBioGen Competitive Strengths & Weaknesses
7.14 Goodwin Biotechnology
7.14.1 Goodwin Biotechnology Details
7.14.2 Goodwin Biotechnology Major Business
7.14.3 Goodwin Biotechnology Biomacromolecule CDMO Product and Services
7.14.4 Goodwin Biotechnology Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Goodwin Biotechnology Recent Developments/Updates
7.14.6 Goodwin Biotechnology Competitive Strengths & Weaknesses
7.15 KBI Biopharma
7.15.1 KBI Biopharma Details
7.15.2 KBI Biopharma Major Business
7.15.3 KBI Biopharma Biomacromolecule CDMO Product and Services
7.15.4 KBI Biopharma Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 KBI Biopharma Recent Developments/Updates
7.15.6 KBI Biopharma Competitive Strengths & Weaknesses
7.16 Asymchem Laboratories (Tianjin) Co., Ltd.
7.16.1 Asymchem Laboratories (Tianjin) Co., Ltd. Details
7.16.2 Asymchem Laboratories (Tianjin) Co., Ltd. Major Business
7.16.3 Asymchem Laboratories (Tianjin) Co., Ltd. Biomacromolecule CDMO Product and Services
7.16.4 Asymchem Laboratories (Tianjin) Co., Ltd. Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Asymchem Laboratories (Tianjin) Co., Ltd. Recent Developments/Updates
7.16.6 Asymchem Laboratories (Tianjin) Co., Ltd. Competitive Strengths & Weaknesses
7.17 Shanghai Chempartner Lifescience Co., Ltd.
7.17.1 Shanghai Chempartner Lifescience Co., Ltd. Details
7.17.2 Shanghai Chempartner Lifescience Co., Ltd. Major Business
7.17.3 Shanghai Chempartner Lifescience Co., Ltd. Biomacromolecule CDMO Product and Services
7.17.4 Shanghai Chempartner Lifescience Co., Ltd. Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Shanghai Chempartner Lifescience Co., Ltd. Recent Developments/Updates
7.17.6 Shanghai Chempartner Lifescience Co., Ltd. Competitive Strengths & Weaknesses
7.18 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd.
7.18.1 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Details
7.18.2 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Major Business
7.18.3 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Biomacromolecule CDMO Product and Services
7.18.4 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Recent Developments/Updates
7.18.6 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
7.19 Genscript Biotech
7.19.1 Genscript Biotech Details
7.19.2 Genscript Biotech Major Business
7.19.3 Genscript Biotech Biomacromolecule CDMO Product and Services
7.19.4 Genscript Biotech Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Genscript Biotech Recent Developments/Updates
7.19.6 Genscript Biotech Competitive Strengths & Weaknesses
7.20 Beijing Joinn Biologics Co., Ltd.
7.20.1 Beijing Joinn Biologics Co., Ltd. Details
7.20.2 Beijing Joinn Biologics Co., Ltd. Major Business
7.20.3 Beijing Joinn Biologics Co., Ltd. Biomacromolecule CDMO Product and Services
7.20.4 Beijing Joinn Biologics Co., Ltd. Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Beijing Joinn Biologics Co., Ltd. Recent Developments/Updates
7.20.6 Beijing Joinn Biologics Co., Ltd. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Biomacromolecule CDMO Industry Chain
8.2 Biomacromolecule CDMO Upstream Analysis
8.3 Biomacromolecule CDMO Midstream Analysis
8.4 Biomacromolecule CDMO Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Biomacromolecule CDMO Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Biomacromolecule CDMO Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Biomacromolecule CDMO Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Biomacromolecule CDMO Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Biomacromolecule CDMO Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Biomacromolecule CDMO Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Biomacromolecule CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Biomacromolecule CDMO Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Biomacromolecule CDMO Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Biomacromolecule CDMO Players in 2022
Table 12. World Biomacromolecule CDMO Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Biomacromolecule CDMO Company Evaluation Quadrant
Table 14. Head Office of Key Biomacromolecule CDMO Player
Table 15. Biomacromolecule CDMO Market: Company Product Type Footprint
Table 16. Biomacromolecule CDMO Market: Company Product Application Footprint
Table 17. Biomacromolecule CDMO Mergers & Acquisitions Activity
Table 18. United States VS China Biomacromolecule CDMO Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Biomacromolecule CDMO Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Biomacromolecule CDMO Companies, Headquarters (States, Country)
Table 21. United States Based Companies Biomacromolecule CDMO Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Biomacromolecule CDMO Revenue Market Share (2018-2023)
Table 23. China Based Biomacromolecule CDMO Companies, Headquarters (Province, Country)
Table 24. China Based Companies Biomacromolecule CDMO Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Biomacromolecule CDMO Revenue Market Share (2018-2023)
Table 26. Rest of World Based Biomacromolecule CDMO Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Biomacromolecule CDMO Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Biomacromolecule CDMO Revenue Market Share (2018-2023)
Table 29. World Biomacromolecule CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Biomacromolecule CDMO Market Size by Type (2018-2023) & (USD Million)
Table 31. World Biomacromolecule CDMO Market Size by Type (2024-2029) & (USD Million)
Table 32. World Biomacromolecule CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Biomacromolecule CDMO Market Size by Application (2018-2023) & (USD Million)
Table 34. World Biomacromolecule CDMO Market Size by Application (2024-2029) & (USD Million)
Table 35. Lonza Basic Information, Area Served and Competitors
Table 36. Lonza Major Business
Table 37. Lonza Biomacromolecule CDMO Product and Services
Table 38. Lonza Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Lonza Recent Developments/Updates
Table 40. Lonza Competitive Strengths & Weaknesses
Table 41. Wuxi Biologics (Cayman) Inc. Basic Information, Area Served and Competitors
Table 42. Wuxi Biologics (Cayman) Inc. Major Business
Table 43. Wuxi Biologics (Cayman) Inc. Biomacromolecule CDMO Product and Services
Table 44. Wuxi Biologics (Cayman) Inc. Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Wuxi Biologics (Cayman) Inc. Recent Developments/Updates
Table 46. Wuxi Biologics (Cayman) Inc. Competitive Strengths & Weaknesses
Table 47. Catalent Basic Information, Area Served and Competitors
Table 48. Catalent Major Business
Table 49. Catalent Biomacromolecule CDMO Product and Services
Table 50. Catalent Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Catalent Recent Developments/Updates
Table 52. Catalent Competitive Strengths & Weaknesses
Table 53. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 54. Thermo Fisher Scientific Major Business
Table 55. Thermo Fisher Scientific Biomacromolecule CDMO Product and Services
Table 56. Thermo Fisher Scientific Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Thermo Fisher Scientific Recent Developments/Updates
Table 58. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 59. Samsung Biologics Basic Information, Area Served and Competitors
Table 60. Samsung Biologics Major Business
Table 61. Samsung Biologics Biomacromolecule CDMO Product and Services
Table 62. Samsung Biologics Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Samsung Biologics Recent Developments/Updates
Table 64. Samsung Biologics Competitive Strengths & Weaknesses
Table 65. Rentschler Biopharma Basic Information, Area Served and Competitors
Table 66. Rentschler Biopharma Major Business
Table 67. Rentschler Biopharma Biomacromolecule CDMO Product and Services
Table 68. Rentschler Biopharma Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Rentschler Biopharma Recent Developments/Updates
Table 70. Rentschler Biopharma Competitive Strengths & Weaknesses
Table 71. Baxter Biopharma Solutions Basic Information, Area Served and Competitors
Table 72. Baxter Biopharma Solutions Major Business
Table 73. Baxter Biopharma Solutions Biomacromolecule CDMO Product and Services
Table 74. Baxter Biopharma Solutions Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Baxter Biopharma Solutions Recent Developments/Updates
Table 76. Baxter Biopharma Solutions Competitive Strengths & Weaknesses
Table 77. Merck BioReliance Basic Information, Area Served and Competitors
Table 78. Merck BioReliance Major Business
Table 79. Merck BioReliance Biomacromolecule CDMO Product and Services
Table 80. Merck BioReliance Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Merck BioReliance Recent Developments/Updates
Table 82. Merck BioReliance Competitive Strengths & Weaknesses
Table 83. Cytovance Biologics Basic Information, Area Served and Competitors
Table 84. Cytovance Biologics Major Business
Table 85. Cytovance Biologics Biomacromolecule CDMO Product and Services
Table 86. Cytovance Biologics Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Cytovance Biologics Recent Developments/Updates
Table 88. Cytovance Biologics Competitive Strengths & Weaknesses
Table 89. AGC Biologics Basic Information, Area Served and Competitors
Table 90. AGC Biologics Major Business
Table 91. AGC Biologics Biomacromolecule CDMO Product and Services
Table 92. AGC Biologics Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. AGC Biologics Recent Developments/Updates
Table 94. AGC Biologics Competitive Strengths & Weaknesses
Table 95. Abzena Basic Information, Area Served and Competitors
Table 96. Abzena Major Business
Table 97. Abzena Biomacromolecule CDMO Product and Services
Table 98. Abzena Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Abzena Recent Developments/Updates
Table 100. Abzena Competitive Strengths & Weaknesses
Table 101. Emergent BioSolutions Basic Information, Area Served and Competitors
Table 102. Emergent BioSolutions Major Business
Table 103. Emergent BioSolutions Biomacromolecule CDMO Product and Services
Table 104. Emergent BioSolutions Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Emergent BioSolutions Recent Developments/Updates
Table 106. Emergent BioSolutions Competitive Strengths & Weaknesses
Table 107. ProBioGen Basic Information, Area Served and Competitors
Table 108. ProBioGen Major Business
Table 109. ProBioGen Biomacromolecule CDMO Product and Services
Table 110. ProBioGen Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. ProBioGen Recent Developments/Updates
Table 112. ProBioGen Competitive Strengths & Weaknesses
Table 113. Goodwin Biotechnology Basic Information, Area Served and Competitors
Table 114. Goodwin Biotechnology Major Business
Table 115. Goodwin Biotechnology Biomacromolecule CDMO Product and Services
Table 116. Goodwin Biotechnology Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Goodwin Biotechnology Recent Developments/Updates
Table 118. Goodwin Biotechnology Competitive Strengths & Weaknesses
Table 119. KBI Biopharma Basic Information, Area Served and Competitors
Table 120. KBI Biopharma Major Business
Table 121. KBI Biopharma Biomacromolecule CDMO Product and Services
Table 122. KBI Biopharma Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. KBI Biopharma Recent Developments/Updates
Table 124. KBI Biopharma Competitive Strengths & Weaknesses
Table 125. Asymchem Laboratories (Tianjin) Co., Ltd. Basic Information, Area Served and Competitors
Table 126. Asymchem Laboratories (Tianjin) Co., Ltd. Major Business
Table 127. Asymchem Laboratories (Tianjin) Co., Ltd. Biomacromolecule CDMO Product and Services
Table 128. Asymchem Laboratories (Tianjin) Co., Ltd. Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Asymchem Laboratories (Tianjin) Co., Ltd. Recent Developments/Updates
Table 130. Asymchem Laboratories (Tianjin) Co., Ltd. Competitive Strengths & Weaknesses
Table 131. Shanghai Chempartner Lifescience Co., Ltd. Basic Information, Area Served and Competitors
Table 132. Shanghai Chempartner Lifescience Co., Ltd. Major Business
Table 133. Shanghai Chempartner Lifescience Co., Ltd. Biomacromolecule CDMO Product and Services
Table 134. Shanghai Chempartner Lifescience Co., Ltd. Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Shanghai Chempartner Lifescience Co., Ltd. Recent Developments/Updates
Table 136. Shanghai Chempartner Lifescience Co., Ltd. Competitive Strengths & Weaknesses
Table 137. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Basic Information, Area Served and Competitors
Table 138. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Major Business
Table 139. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Biomacromolecule CDMO Product and Services
Table 140. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Recent Developments/Updates
Table 142. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
Table 143. Genscript Biotech Basic Information, Area Served and Competitors
Table 144. Genscript Biotech Major Business
Table 145. Genscript Biotech Biomacromolecule CDMO Product and Services
Table 146. Genscript Biotech Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Genscript Biotech Recent Developments/Updates
Table 148. Beijing Joinn Biologics Co., Ltd. Basic Information, Area Served and Competitors
Table 149. Beijing Joinn Biologics Co., Ltd. Major Business
Table 150. Beijing Joinn Biologics Co., Ltd. Biomacromolecule CDMO Product and Services
Table 151. Beijing Joinn Biologics Co., Ltd. Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 152. Global Key Players of Biomacromolecule CDMO Upstream (Raw Materials)
Table 153. Biomacromolecule CDMO Typical Customers
LIST OF FIGURE
Figure 1. Biomacromolecule CDMO Picture
Figure 2. World Biomacromolecule CDMO Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Biomacromolecule CDMO Total Market Size (2018-2029) & (USD Million)
Figure 4. World Biomacromolecule CDMO Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Biomacromolecule CDMO Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Biomacromolecule CDMO Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Biomacromolecule CDMO Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Biomacromolecule CDMO Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Biomacromolecule CDMO Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Biomacromolecule CDMO Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Biomacromolecule CDMO Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Biomacromolecule CDMO Revenue (2018-2029) & (USD Million)
Figure 13. Biomacromolecule CDMO Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Biomacromolecule CDMO Consumption Value (2018-2029) & (USD Million)
Figure 16. World Biomacromolecule CDMO Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Biomacromolecule CDMO Consumption Value (2018-2029) & (USD Million)
Figure 18. China Biomacromolecule CDMO Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Biomacromolecule CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Biomacromolecule CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Biomacromolecule CDMO Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Biomacromolecule CDMO Consumption Value (2018-2029) & (USD Million)
Figure 23. India Biomacromolecule CDMO Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Biomacromolecule CDMO by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Biomacromolecule CDMO Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Biomacromolecule CDMO Markets in 2022
Figure 27. United States VS China: Biomacromolecule CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Biomacromolecule CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Biomacromolecule CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Biomacromolecule CDMO Market Size Market Share by Type in 2022
Figure 31. Biologics CDMO
Figure 32. Viral Vaccine Production CDMO
Figure 33. Analyze and Test CDMOs
Figure 34. Others
Figure 35. World Biomacromolecule CDMO Market Size Market Share by Type (2018-2029)
Figure 36. World Biomacromolecule CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Biomacromolecule CDMO Market Size Market Share by Application in 2022
Figure 38. Drug Development
Figure 39. Vaccine Production
Figure 40. Technology Transfer
Figure 41. Others
Figure 42. Biomacromolecule CDMO Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Table 1. World Biomacromolecule CDMO Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Biomacromolecule CDMO Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Biomacromolecule CDMO Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Biomacromolecule CDMO Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Biomacromolecule CDMO Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Biomacromolecule CDMO Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Biomacromolecule CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Biomacromolecule CDMO Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Biomacromolecule CDMO Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Biomacromolecule CDMO Players in 2022
Table 12. World Biomacromolecule CDMO Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Biomacromolecule CDMO Company Evaluation Quadrant
Table 14. Head Office of Key Biomacromolecule CDMO Player
Table 15. Biomacromolecule CDMO Market: Company Product Type Footprint
Table 16. Biomacromolecule CDMO Market: Company Product Application Footprint
Table 17. Biomacromolecule CDMO Mergers & Acquisitions Activity
Table 18. United States VS China Biomacromolecule CDMO Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Biomacromolecule CDMO Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Biomacromolecule CDMO Companies, Headquarters (States, Country)
Table 21. United States Based Companies Biomacromolecule CDMO Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Biomacromolecule CDMO Revenue Market Share (2018-2023)
Table 23. China Based Biomacromolecule CDMO Companies, Headquarters (Province, Country)
Table 24. China Based Companies Biomacromolecule CDMO Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Biomacromolecule CDMO Revenue Market Share (2018-2023)
Table 26. Rest of World Based Biomacromolecule CDMO Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Biomacromolecule CDMO Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Biomacromolecule CDMO Revenue Market Share (2018-2023)
Table 29. World Biomacromolecule CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Biomacromolecule CDMO Market Size by Type (2018-2023) & (USD Million)
Table 31. World Biomacromolecule CDMO Market Size by Type (2024-2029) & (USD Million)
Table 32. World Biomacromolecule CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Biomacromolecule CDMO Market Size by Application (2018-2023) & (USD Million)
Table 34. World Biomacromolecule CDMO Market Size by Application (2024-2029) & (USD Million)
Table 35. Lonza Basic Information, Area Served and Competitors
Table 36. Lonza Major Business
Table 37. Lonza Biomacromolecule CDMO Product and Services
Table 38. Lonza Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Lonza Recent Developments/Updates
Table 40. Lonza Competitive Strengths & Weaknesses
Table 41. Wuxi Biologics (Cayman) Inc. Basic Information, Area Served and Competitors
Table 42. Wuxi Biologics (Cayman) Inc. Major Business
Table 43. Wuxi Biologics (Cayman) Inc. Biomacromolecule CDMO Product and Services
Table 44. Wuxi Biologics (Cayman) Inc. Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Wuxi Biologics (Cayman) Inc. Recent Developments/Updates
Table 46. Wuxi Biologics (Cayman) Inc. Competitive Strengths & Weaknesses
Table 47. Catalent Basic Information, Area Served and Competitors
Table 48. Catalent Major Business
Table 49. Catalent Biomacromolecule CDMO Product and Services
Table 50. Catalent Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Catalent Recent Developments/Updates
Table 52. Catalent Competitive Strengths & Weaknesses
Table 53. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 54. Thermo Fisher Scientific Major Business
Table 55. Thermo Fisher Scientific Biomacromolecule CDMO Product and Services
Table 56. Thermo Fisher Scientific Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Thermo Fisher Scientific Recent Developments/Updates
Table 58. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 59. Samsung Biologics Basic Information, Area Served and Competitors
Table 60. Samsung Biologics Major Business
Table 61. Samsung Biologics Biomacromolecule CDMO Product and Services
Table 62. Samsung Biologics Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Samsung Biologics Recent Developments/Updates
Table 64. Samsung Biologics Competitive Strengths & Weaknesses
Table 65. Rentschler Biopharma Basic Information, Area Served and Competitors
Table 66. Rentschler Biopharma Major Business
Table 67. Rentschler Biopharma Biomacromolecule CDMO Product and Services
Table 68. Rentschler Biopharma Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Rentschler Biopharma Recent Developments/Updates
Table 70. Rentschler Biopharma Competitive Strengths & Weaknesses
Table 71. Baxter Biopharma Solutions Basic Information, Area Served and Competitors
Table 72. Baxter Biopharma Solutions Major Business
Table 73. Baxter Biopharma Solutions Biomacromolecule CDMO Product and Services
Table 74. Baxter Biopharma Solutions Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Baxter Biopharma Solutions Recent Developments/Updates
Table 76. Baxter Biopharma Solutions Competitive Strengths & Weaknesses
Table 77. Merck BioReliance Basic Information, Area Served and Competitors
Table 78. Merck BioReliance Major Business
Table 79. Merck BioReliance Biomacromolecule CDMO Product and Services
Table 80. Merck BioReliance Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Merck BioReliance Recent Developments/Updates
Table 82. Merck BioReliance Competitive Strengths & Weaknesses
Table 83. Cytovance Biologics Basic Information, Area Served and Competitors
Table 84. Cytovance Biologics Major Business
Table 85. Cytovance Biologics Biomacromolecule CDMO Product and Services
Table 86. Cytovance Biologics Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Cytovance Biologics Recent Developments/Updates
Table 88. Cytovance Biologics Competitive Strengths & Weaknesses
Table 89. AGC Biologics Basic Information, Area Served and Competitors
Table 90. AGC Biologics Major Business
Table 91. AGC Biologics Biomacromolecule CDMO Product and Services
Table 92. AGC Biologics Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. AGC Biologics Recent Developments/Updates
Table 94. AGC Biologics Competitive Strengths & Weaknesses
Table 95. Abzena Basic Information, Area Served and Competitors
Table 96. Abzena Major Business
Table 97. Abzena Biomacromolecule CDMO Product and Services
Table 98. Abzena Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Abzena Recent Developments/Updates
Table 100. Abzena Competitive Strengths & Weaknesses
Table 101. Emergent BioSolutions Basic Information, Area Served and Competitors
Table 102. Emergent BioSolutions Major Business
Table 103. Emergent BioSolutions Biomacromolecule CDMO Product and Services
Table 104. Emergent BioSolutions Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Emergent BioSolutions Recent Developments/Updates
Table 106. Emergent BioSolutions Competitive Strengths & Weaknesses
Table 107. ProBioGen Basic Information, Area Served and Competitors
Table 108. ProBioGen Major Business
Table 109. ProBioGen Biomacromolecule CDMO Product and Services
Table 110. ProBioGen Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. ProBioGen Recent Developments/Updates
Table 112. ProBioGen Competitive Strengths & Weaknesses
Table 113. Goodwin Biotechnology Basic Information, Area Served and Competitors
Table 114. Goodwin Biotechnology Major Business
Table 115. Goodwin Biotechnology Biomacromolecule CDMO Product and Services
Table 116. Goodwin Biotechnology Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Goodwin Biotechnology Recent Developments/Updates
Table 118. Goodwin Biotechnology Competitive Strengths & Weaknesses
Table 119. KBI Biopharma Basic Information, Area Served and Competitors
Table 120. KBI Biopharma Major Business
Table 121. KBI Biopharma Biomacromolecule CDMO Product and Services
Table 122. KBI Biopharma Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. KBI Biopharma Recent Developments/Updates
Table 124. KBI Biopharma Competitive Strengths & Weaknesses
Table 125. Asymchem Laboratories (Tianjin) Co., Ltd. Basic Information, Area Served and Competitors
Table 126. Asymchem Laboratories (Tianjin) Co., Ltd. Major Business
Table 127. Asymchem Laboratories (Tianjin) Co., Ltd. Biomacromolecule CDMO Product and Services
Table 128. Asymchem Laboratories (Tianjin) Co., Ltd. Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Asymchem Laboratories (Tianjin) Co., Ltd. Recent Developments/Updates
Table 130. Asymchem Laboratories (Tianjin) Co., Ltd. Competitive Strengths & Weaknesses
Table 131. Shanghai Chempartner Lifescience Co., Ltd. Basic Information, Area Served and Competitors
Table 132. Shanghai Chempartner Lifescience Co., Ltd. Major Business
Table 133. Shanghai Chempartner Lifescience Co., Ltd. Biomacromolecule CDMO Product and Services
Table 134. Shanghai Chempartner Lifescience Co., Ltd. Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Shanghai Chempartner Lifescience Co., Ltd. Recent Developments/Updates
Table 136. Shanghai Chempartner Lifescience Co., Ltd. Competitive Strengths & Weaknesses
Table 137. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Basic Information, Area Served and Competitors
Table 138. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Major Business
Table 139. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Biomacromolecule CDMO Product and Services
Table 140. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Recent Developments/Updates
Table 142. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
Table 143. Genscript Biotech Basic Information, Area Served and Competitors
Table 144. Genscript Biotech Major Business
Table 145. Genscript Biotech Biomacromolecule CDMO Product and Services
Table 146. Genscript Biotech Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Genscript Biotech Recent Developments/Updates
Table 148. Beijing Joinn Biologics Co., Ltd. Basic Information, Area Served and Competitors
Table 149. Beijing Joinn Biologics Co., Ltd. Major Business
Table 150. Beijing Joinn Biologics Co., Ltd. Biomacromolecule CDMO Product and Services
Table 151. Beijing Joinn Biologics Co., Ltd. Biomacromolecule CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 152. Global Key Players of Biomacromolecule CDMO Upstream (Raw Materials)
Table 153. Biomacromolecule CDMO Typical Customers
LIST OF FIGURE
Figure 1. Biomacromolecule CDMO Picture
Figure 2. World Biomacromolecule CDMO Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Biomacromolecule CDMO Total Market Size (2018-2029) & (USD Million)
Figure 4. World Biomacromolecule CDMO Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Biomacromolecule CDMO Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Biomacromolecule CDMO Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Biomacromolecule CDMO Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Biomacromolecule CDMO Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Biomacromolecule CDMO Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Biomacromolecule CDMO Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Biomacromolecule CDMO Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Biomacromolecule CDMO Revenue (2018-2029) & (USD Million)
Figure 13. Biomacromolecule CDMO Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Biomacromolecule CDMO Consumption Value (2018-2029) & (USD Million)
Figure 16. World Biomacromolecule CDMO Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Biomacromolecule CDMO Consumption Value (2018-2029) & (USD Million)
Figure 18. China Biomacromolecule CDMO Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Biomacromolecule CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Biomacromolecule CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Biomacromolecule CDMO Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Biomacromolecule CDMO Consumption Value (2018-2029) & (USD Million)
Figure 23. India Biomacromolecule CDMO Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Biomacromolecule CDMO by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Biomacromolecule CDMO Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Biomacromolecule CDMO Markets in 2022
Figure 27. United States VS China: Biomacromolecule CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Biomacromolecule CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Biomacromolecule CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Biomacromolecule CDMO Market Size Market Share by Type in 2022
Figure 31. Biologics CDMO
Figure 32. Viral Vaccine Production CDMO
Figure 33. Analyze and Test CDMOs
Figure 34. Others
Figure 35. World Biomacromolecule CDMO Market Size Market Share by Type (2018-2029)
Figure 36. World Biomacromolecule CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Biomacromolecule CDMO Market Size Market Share by Application in 2022
Figure 38. Drug Development
Figure 39. Vaccine Production
Figure 40. Technology Transfer
Figure 41. Others
Figure 42. Biomacromolecule CDMO Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
